Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. OBJECTIVE: To determine whether ivermectin treatment can pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallejos, Julio, Zoni, Rodrigo, Bangher, María, Villamandos, Silvina, Bobadilla, Angelina, Plano, Fabian, Campias, Claudia, Chaparro Campias, Evangelina, Medina, Maria Fernanda, Achinelli, Fernando, Guglielmone, Hector Andres, Ojeda, Jorge, Farizano Salazar, Diego, Andino, Gerardo, Kawerin, Pablo, Dellamea, Silvana, Aquino, Antonia Cristina, Flores, Victor, Martemucci, Carolina N., Martinez, Silvina Maria, Segovia, Juan Emanuel, Reynoso, Paola Itati, Sosa, Noelia Carolina, Robledo, Mariana Elizabeth, Guarrochena, Joaquina Maria, Vernengo, Maria Mercedes, Ruiz Diaz, Natalia, Meza, Elba, Aguirre, María Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250562/
https://www.ncbi.nlm.nih.gov/pubmed/34215210
http://dx.doi.org/10.1186/s12879-021-06348-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250562/
https://www.ncbi.nlm.nih.gov/pubmed/34215210
http://dx.doi.org/10.1186/s12879-021-06348-5

Ejemplares similares